B

Bioventus Inc
NASDAQ:BVS

Watchlist Manager
Bioventus Inc
NASDAQ:BVS
Watchlist
Price: 11.13 USD -0.27% Market Closed
Market Cap: 901.2m USD
Have any thoughts about
Bioventus Inc?
Write Note

Bioventus Inc
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bioventus Inc
Depreciation & Amortization Peer Comparison

Comparables:
HAE
ICUI
ALGN
LNTH
MMSI

Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
B
Bioventus Inc
NASDAQ:BVS
Depreciation & Amortization
$57.4m
CAGR 3-Years
26%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Haemonetics Corp
NYSE:HAE
Depreciation & Amortization
$109.6m
CAGR 3-Years
6%
CAGR 5-Years
0%
CAGR 10-Years
3%
ICU Medical Inc
NASDAQ:ICUI
Depreciation & Amortization
$226.4m
CAGR 3-Years
37%
CAGR 5-Years
24%
CAGR 10-Years
28%
Align Technology Inc
NASDAQ:ALGN
Depreciation & Amortization
$139.9m
CAGR 3-Years
10%
CAGR 5-Years
14%
CAGR 10-Years
25%
Lantheus Holdings Inc
NASDAQ:LNTH
Depreciation & Amortization
$62.4m
CAGR 3-Years
17%
CAGR 5-Years
36%
CAGR 10-Years
13%
Merit Medical Systems Inc
NASDAQ:MMSI
Depreciation & Amortization
$97.7m
CAGR 3-Years
4%
CAGR 5-Years
2%
CAGR 10-Years
11%

See Also

What is Bioventus Inc's Depreciation & Amortization?
Depreciation & Amortization
57.4m USD

Based on the financial report for Dec 31, 2023, Bioventus Inc's Depreciation & Amortization amounts to 57.4m USD.

What is Bioventus Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
14%

Over the last year, the Depreciation & Amortization growth was -14%. The average annual Depreciation & Amortization growth rates for Bioventus Inc have been 26% over the past three years , 14% over the past five years .

Back to Top